I kliniske forsøg havde en daglig dosis på 10- 30 mg aripiprazol ingen signifikant effekt på metabolismen af CYP2D6- substrater (dextromethorphan/ 3- methoxymorphinan forholdet), 2C9 (warfarin), 2C19 (omeprazol) og 3A4 (dextromethorphan).
In clinical studies, 10-30 mg/ day doses of aripiprazole had no significant effect on the metabolism of substrates of CYP2D6 (dextromethorphan/ 3-methoxymorphinan ratio), 2C9 (warfarin), 2C19 (omeprazole), and 3A4 (dextromethorphan).